Vulvar Tumors

Vulvar neoplasms are growths or tumors found on the vulva. These can be benign (not cancer) or malignant (cancer). A doctor would diagnose these growths and determine the best course of action.

Condition

What people with Vulvar Tumors report

Every report comes from a Lived member, sent anonymously.

Have you had Vulvectomy for Vulvar Tumors?

NameHow it went

About Vulvar Tumors

What It Is

Vulvar tumors are abnormal growths on the vulva, the external female genitals that include the inner and outer lips (labia), the clitoris and the skin around the vaginal opening. Some growths are noncancerous, but the term is most often used for vulvar cancer and the precancerous changes that can come before it. Vulvar cancer is rare: in the United States it makes up about 6% of cancers of the female reproductive organs. Most vulvar cancers are squamous cell carcinomas, which start in the flat cells that make up the skin's surface. They usually develop slowly over years, often beginning as vulvar intraepithelial neoplasia (VIN), abnormal cells confined to the top layer of skin. VIN is not cancer, and most cases never become cancer, but because no one can tell in advance which will, it is treated or closely watched. Less common types include melanoma, which starts in pigment cells, as well as basal cell carcinoma, Paget disease of the vulva and cancers of the Bartholin glands near the vaginal opening.

Causes & Risk Factors

Age is the strongest risk factor. The average age at diagnosis of invasive vulvar cancer is about 70, and fewer than 1 in 5 cases occur before 50. Vulvar squamous cancer tends to follow one of two paths. About half of cases are caused by long-lasting infection with a high-risk type of human papillomavirus (HPV), a common virus spread by skin-to-skin sexual contact. These tend to affect younger women and share risk factors with cervical cancer, including a history of genital warts, abnormal Pap tests and many sexual partners. The other path does not involve HPV and is more common in older women. It is linked to lichen sclerosus, a long-term inflammatory skin condition that makes vulvar skin thin, white and itchy; about 4% of women with it later develop vulvar cancer. Smoking raises risk, especially for people who also have high-risk HPV, and HIV (human immunodeficiency virus), by weakening the immune system, makes HPV infection harder to clear. These factors make vulvar cancer more likely but do not mean any one of them caused a particular case. The HPV vaccine Gardasil 9, approved for ages 9 through 45, protects against the HPV types behind most HPV-related vulvar precancers and cancers. It works best before any exposure to HPV and does not treat an infection that is already present.

How It's Diagnosed

Evaluation starts with a look at the vulva and a pelvic exam. A clinician may use a colposcope, a lighted magnifying instrument, to examine the skin more closely. The only way to know whether a spot is VIN, cancer or something harmless is a biopsy: a small piece of tissue is removed and examined under a microscope. Biopsy matters because VIN and early cancer can look like common problems such as an irritated rash, a wart or a cyst. Pap and HPV tests may be done at the same visit, but they screen for cervical disease and do not rule out vulvar cancer. If cancer is found, staging describes how far it has spread. Imaging scans such as magnetic resonance imaging (MRI), computed tomography (CT) or positron emission tomography (PET), and sometimes examinations of the bladder or rectum, show whether it has reached the groin lymph nodes or nearby organs. In stage I the cancer is confined to the vulva; higher stages mean spread to nearby structures, the lymph nodes or distant organs. Melanoma of the vulva is staged the same way as melanoma elsewhere on the skin.

Treatment Options

Treatment depends on the type of growth, its stage and the person's overall health, and is usually led by a gynecologic oncologist, a surgeon who specializes in cancers of the female reproductive organs. For VIN, the aim is to remove the abnormal skin while keeping as much normal anatomy as possible. Options include cutting out the affected area, laser treatment that removes the surface layer, and imiquimod, a prescription cream that stimulates the skin's immune response. VIN can return, so follow-up continues after treatment. Surgery is the main treatment for vulvar cancer. Small cancers can often be removed with a margin of healthy tissue (wide local excision), while larger ones may need removal of part or all of the vulva (vulvectomy). Surgeons try to preserve sexual function and urinary and bowel control, and reconstructive surgery or skin grafts can be used when a large area is removed. Because vulvar cancer often spreads first to lymph nodes in the groin, these nodes are usually checked. For many smaller tumors, a sentinel lymph node biopsy removes only the one or few nodes the cancer would reach first. If they are clear, a full groin dissection can often be avoided, which greatly reduces the risk of long-term leg swelling. Radiation, often given together with chemotherapy, is used when nodes contain cancer, when cancer remains after surgery, or when surgery is not possible. Cancer that has spread to distant organs is treated with drug therapy, and clinical trials are an option because advanced vulvar cancer is uncommon.

What to Expect

Outlook depends most on whether the cancer has reached the groin lymph nodes. When surgery removes cancer that has not spread to the nodes, about 90% of people are alive years later. When nodes are involved, five-year survival is roughly 50% to 60%. These figures come from people treated years ago and cannot predict any one person's course. Recovery from vulvar surgery usually involves a few weeks of pain and swelling, with careful wound care because the area is warm and moist and can become infected. Some effects can last. Removing groin lymph nodes can cause lymphedema, a buildup of fluid that makes a leg or the genital area swell and feel heavy. Surgery can change how the vulva looks and feels, make orgasm harder to reach, or narrow the vaginal opening and make sex painful; vaginal dilators and pelvic floor physical therapy can help. The emotional effect on body image and intimacy is real and worth raising with the care team. Follow-up visits are typically every 3 to 6 months for the first 2 years, every 6 to 12 months through year 5, and then yearly. They look for cancer returning and for new areas of VIN, since the underlying skin changes can affect the whole vulva. People treated for vulvar cancer also have a higher risk of other HPV- and smoking-related cancers, so stopping smoking and keeping up with other screening matter.

When to Seek Help

Arrange a visit with a gynecologist or primary care clinician for vulvar itching that does not go away, a lump or wart-like growth, an open sore that lasts a month or more, an area of skin that becomes thicker or changes color, a mole that changes in size, shape or color, or pain, bleeding or discharge not related to a period. These are more often caused by noncancerous conditions, but repeated self-treatment with over-the-counter creams can delay a diagnosis. People with lichen sclerosus or a history of VIN should keep regular checkups and report any new or changing area. After treatment, contact your care team about new swelling, heaviness or skin changes in the legs or genitals, or a wound that becomes red, hot or increasingly painful.

Questions to Ask Your Doctor

  1. 1.Is this VIN, cancer or something else, and what did the biopsy show about its type?
  2. 2.Has the cancer reached the lymph nodes, and is a sentinel node biopsy an option for me?
  3. 3.How will the treatment you recommend affect how my vulva looks and works, including sex and urination?
  4. 4.What can I do to lower my chance of lymphedema, and what support is available if it develops?
  5. 5.How often will I need checkups, and what changes should I watch for between visits?

Last reviewed • Oct 2026

Educational content, not medical advice.